Trial Profile
A clinical study of a monoclonal antibody using XmAb technology in patients with cancer.
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 23 Apr 2012
Price :
$35
*
At a glance
- Drugs Monoclonal antibodies (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Apr 2012 New trial record